ArticleRheumatology and therapy2023

Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial.

Cory Perugino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.